No Data
No Data
William Blair Maintains PTC Therapeutics(PTCT.US) With Buy Rating
PTC and Jazz Pharmaceuticals Among Latest Firms to Win EU Backing for Drugs
Positive Outlook for PTC Therapeutics: Buy Rating Affirmed Amid European and U.S. Approval Prospects for Sephience
Express News | RPT-EMA Says Chmp Recommended Granting Conditional Marketing Authorisation for Ziihera (Zanidatamab)
Express News | RPT-EMA Says Tepezza (Teprotumumab) Received Positive Opinion From Chmp for Treatment of Adults With Moderate to Severe Thyroid Eye Disease
Express News | RPT-EMA Says Chmp Recommends Conditional Marketing Authorisation for Duvyzat (Givinostat), as Treatment for Dmd in Patients From Age Six Who Can Walk